Ib-U-Ron

Ibuprofen, the active ingredient in Ib-U-Ron, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a rectal suppository for rectal use. It is employed to relieve pain, reduce fever, and lessen inflammation in patients requiring non‑oral administration.

GNH USA supplies Ib-U-Ron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts systemically to manage common inflammatory and febrile conditions. - Pain: provides analgesia for mild to moderate acute pain such as headache, dental or musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with infections or inflammatory states. - Inflammation: reduces swelling and redness in conditions like arthritis or soft‑tissue injury.

Adverse reactions may occur with ibuprofen use and vary in frequency and severity.

Common Side Effects: - Dyspepsia or stomach discomfort - Nausea or mild vomiting - Diarrhea or constipation - Headache - Dizziness - Mild skin rash

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe allergic reactions (e.g., anaphylaxis, Stevens‑Johnson syndrome) - Renal impairment or failure - Hepatotoxicity - Cardiovascular events such as myocardial infarction or stroke - Hematologic abnormalities (e.g., thrombocytopenia)

Before using Ib-U-Ron, consider the following safety measures. - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Evaluate renal function: use cautiously in those with impaired kidney function. - Monitor cardiovascular status: limit use in patients with established heart disease. - Review concomitant medications: avoid concurrent use with other NSAIDs or anticoagulants without medical guidance. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Store at room temperature: keep below 25 °C, protect from moisture and direct sunlight in the original packaging.

Ibuprofen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - High‑dose aspirin: heightened gastrointestinal toxicity. - Certain antihypertensives (e.g., ACE inhibitors, ARBs): may reduce blood‑pressure control.

Moderate Interactions (Monitor Closely): - Other NSAIDs or COX‑2 inhibitors: additive renal and GI effects. - Lithium: ibuprofen may raise lithium serum levels. - Methotrexate (high dose): reduced renal clearance leading to toxicity. - SSRIs or SNRIs: increased potential for GI bleeding.